REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 159 filers reported holding REVANCE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $692 | -99.9% | 27,345 | -62.0% | 0.01% | -50.0% |
| Q2 2022 | $995,000 | +38.4% | 71,966 | +63.4% | 0.01% | +71.4% |
| Q4 2021 | $719,000 | -18.0% | 44,037 | +39.9% | 0.01% | -41.7% |
| Q3 2021 | $877,000 | -8.3% | 31,472 | -2.4% | 0.01% | +9.1% |
| Q2 2021 | $956,000 | +5.9% | 32,250 | -0.2% | 0.01% | -15.4% |
| Q1 2021 | $903,000 | +92.9% | 32,319 | +95.8% | 0.01% | +160.0% |
| Q4 2020 | $468,000 | -78.3% | 16,507 | -80.7% | 0.01% | -88.4% |
| Q3 2020 | $2,153,000 | +78.5% | 85,659 | +73.4% | 0.04% | +38.7% |
| Q2 2020 | $1,206,000 | +531.4% | 49,396 | +319.9% | 0.03% | +675.0% |
| Q4 2019 | $191,000 | – | 11,765 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $52,671,000 | 26.22% |
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $24,561,000 | 22.85% |
| Sio Capital Management, LLC | 254,581 | $4,012,000 | 1.08% |
| ArrowMark Colorado Holdings LLC | 3,409,217 | $53,729,000 | 0.51% |
| Fosun International Ltd | 472,532 | $7,447,000 | 0.47% |
| Rhenman & Partners Asset Management AB | 193,181 | $3,045,000 | 0.36% |
| Phoenix Investment Adviser LLC | 4,900 | $77,000 | 0.17% |
| HARBOURVEST PARTNERS LLC | 26,565 | $419,000 | 0.15% |
| Quinn Opportunity Partners LLC | 56,672 | $893,000 | 0.12% |
| MFN Partners Management, LP | 46,000 | $725,000 | 0.12% |